Sharad Yadav admitted to AIIMS post complaints of chest pain

Published On 2015-07-03 11:32 GMT   |   Update On 2015-07-03 11:32 GMT
 Sharad Yadav now undergoing treatment for lung infection

The JD(U) minister, Sharad Yadav, is being treated in All India Institute of Medical Sciences (AIIMS) in New Delhi for the past 15 days. He was received at the hospital in a state of a nagging chest pain and other complications, which had initially affected his (Sharad Yadav’s) health.

The minister is currently undergoing a treatment for lung infection, and is stated to be out of danger now. He might be discharged soon, as per a recent press statement.

As per the details shared by PTI,

He was admitted to AIIMS on June 22 after he complained of chest pain and other complications.

Though it is around a fortnight since he has been admitted to the hospital, sources close to him said he is now out of danger and is likely to be discharged soon.

"Sharad ji has recovered and is recuperating fast," they said.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News